• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定膀胱癌患者中与铜死亡相关的功能性长链非编码RNA

Identifying functional cuproptosis-related long non-coding RNAs in patients with bladder cancer.

作者信息

Wang Yunchao, Zhao Yihan, Liu Qing, Yang Jiwei, Xu Zhipeng, Du Wenzhi, Tang Guanbao, Zhang Chuanpai, Si Xiaoqing, Wang Jianning

机构信息

Department of Urology, the First Affiliated Hospital of Shandong First Medical University, Jinan, China.

Department of Medical Ultrasound, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.

出版信息

Transl Cancer Res. 2024 Oct 31;13(10):5178-5189. doi: 10.21037/tcr-23-2367. Epub 2024 Oct 29.

DOI:10.21037/tcr-23-2367
PMID:39525026
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11543048/
Abstract

BACKGROUND

Bladder cancer is the most common malignancy of the urinary tract and one of the most common cancers in the world. Cuproptosis is a novel type of cell death associated with tumorigenesis. In this study, we assessed the correlation between cuproptosis-related genes and tumorigenesis. Moreover, we constructed a prognostic signature.

METHODS

Pearson correlation analysis and univariate Cox regression were utilized to extract cuproptosis-related long non-coding RNAs (lncRNAs) predicting prognosis in The Cancer Genome Atlas (TCGA) database. The least absolute shrinkage and selection operator (LASSO) Cox regression was utilized to establish a cuproptosizs-related prognostic signature. A nomogram signature was generated to predict individual survival.

RESULTS

We obtained 19 cuproptosis-related genes and 14 prognostic cuproptosis-related lncRNAs. We constructed a seven-prognostic risk signature. Time-dependent receiver operating characteristic (ROC) curves demonstrated good predictive power (1-, 3-, and 5-year survival rates of 0.711, 0.673, and 0.684, respectively). The high-risk group reported a worse prognosis than the low-risk group, and the risk signature was identified as an independent factor. The biological process of risk-related genes primarily involved tumorigenesis and migration. The high-risk group expressed high chemokines and T cell inhibition and low antigen-presenting cells.

CONCLUSIONS

Cuproptosis-related lncRNAs are central to tumorigenesis, providing a novel therapeutic target for patients with bladder cancer. We constructed an individualized predictive signature based on cuproptosis-related lncRNAs.

摘要

背景

膀胱癌是泌尿系统最常见的恶性肿瘤,也是全球最常见的癌症之一。铜死亡是一种与肿瘤发生相关的新型细胞死亡方式。在本研究中,我们评估了铜死亡相关基因与肿瘤发生之间的相关性。此外,我们构建了一个预后特征。

方法

利用Pearson相关性分析和单变量Cox回归在癌症基因组图谱(TCGA)数据库中提取预测预后的铜死亡相关长链非编码RNA(lncRNA)。利用最小绝对收缩和选择算子(LASSO)Cox回归建立铜死亡相关的预后特征。生成列线图特征以预测个体生存情况。

结果

我们获得了19个铜死亡相关基因和14个与预后相关的铜死亡lncRNA。我们构建了一个包含七个预后因素的风险特征。时间依赖性受试者工作特征(ROC)曲线显示出良好的预测能力(1年、3年和5年生存率分别为0.711、0.673和0.684)。高危组的预后比低危组差,且风险特征被确定为一个独立因素。与风险相关基因的生物学过程主要涉及肿瘤发生和迁移。高危组表达高水平的趋化因子和T细胞抑制因子,以及低水平的抗原呈递细胞。

结论

铜死亡相关lncRNA是肿瘤发生的核心,为膀胱癌患者提供了一个新的治疗靶点。我们基于铜死亡相关lncRNA构建了一个个体化的预测特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/c59f42cdaec4/tcr-13-10-5178-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/a4e3f842a2ca/tcr-13-10-5178-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/ca1e44adc8fa/tcr-13-10-5178-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/e556c537be09/tcr-13-10-5178-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/fe77cd9ee859/tcr-13-10-5178-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/d0eeae93c475/tcr-13-10-5178-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/5f8acaa9287a/tcr-13-10-5178-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/f5dbf87533ae/tcr-13-10-5178-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/c59f42cdaec4/tcr-13-10-5178-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/a4e3f842a2ca/tcr-13-10-5178-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/ca1e44adc8fa/tcr-13-10-5178-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/e556c537be09/tcr-13-10-5178-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/fe77cd9ee859/tcr-13-10-5178-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/d0eeae93c475/tcr-13-10-5178-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/5f8acaa9287a/tcr-13-10-5178-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/f5dbf87533ae/tcr-13-10-5178-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e64/11543048/c59f42cdaec4/tcr-13-10-5178-f8.jpg

相似文献

1
Identifying functional cuproptosis-related long non-coding RNAs in patients with bladder cancer.鉴定膀胱癌患者中与铜死亡相关的功能性长链非编码RNA
Transl Cancer Res. 2024 Oct 31;13(10):5178-5189. doi: 10.21037/tcr-23-2367. Epub 2024 Oct 29.
2
A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia.一种新型的铜死亡相关长链非编码RNA特征:对急性髓系白血病的预后和治疗价值
Front Oncol. 2022 Oct 7;12:966920. doi: 10.3389/fonc.2022.966920. eCollection 2022.
3
Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.构建并验证一种与铜死亡相关的长链非编码RNA特征作为结肠癌的新型稳健预后模型。
Front Oncol. 2022 Jul 28;12:961213. doi: 10.3389/fonc.2022.961213. eCollection 2022.
4
Construction of prognostic risk model of bladder cancer based on cuproptosis-related long non-coding RNAs.基于铜死亡相关长非编码 RNA 的膀胱癌预后风险模型的构建。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Apr 25;52(2):139-147. doi: 10.3724/zdxbyxb-2022-0539.
5
A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.铜死亡相关长链非编码 RNA 风险模型预测肝细胞癌患者的预后和免疫治疗疗效。
Biochem Genet. 2024 Jun;62(3):2332-2351. doi: 10.1007/s10528-023-10539-x. Epub 2023 Oct 29.
6
Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs.基于铜死亡相关 lncRNAs 构建肺腺癌预后模型。
BMC Bioinformatics. 2023 Mar 6;24(1):81. doi: 10.1186/s12859-023-05192-5.
7
Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation.通过生物信息学分析和实验验证相结合,铜死亡相关长链非编码RNA是头颈部鳞状细胞癌患者潜在的预后和免疫反应标志物。
Front Oncol. 2022 Dec 22;12:1030802. doi: 10.3389/fonc.2022.1030802. eCollection 2022.
8
A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma.一种用于预测肺腺癌预后和免疫微环境特征的铜死亡相关长链非编码RNA特征
Transl Lung Cancer Res. 2022 Oct;11(10):2079-2093. doi: 10.21037/tlcr-22-660.
9
A novel cuproptosis-related lncRNA signature predicts the prognosis and immunotherapy for hepatocellular carcinoma.一种新型铜死亡相关 lncRNA 标志物可预测肝细胞癌的预后和免疫治疗效果。
Cancer Biomark. 2023;37(1):13-26. doi: 10.3233/CBM-220259.
10
Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer.七种与铜死亡相关的长链非编码RNA作为预测宫颈癌预后和治疗反应的新型生物标志物
Front Genet. 2022 Sep 20;13:989646. doi: 10.3389/fgene.2022.989646. eCollection 2022.

本文引用的文献

1
Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway.铜死亡:脂酰化三羧酸循环蛋白介导的新型细胞死亡途径。
Signal Transduct Target Ther. 2022 May 13;7(1):158. doi: 10.1038/s41392-022-01014-x.
2
Copper induces cell death by targeting lipoylated TCA cycle proteins.铜通过靶向脂酰化 TCA 循环蛋白诱导细胞死亡。
Science. 2022 Mar 18;375(6586):1254-1261. doi: 10.1126/science.abf0529. Epub 2022 Mar 17.
3
A high monocyte-to-lymphocyte ratio predicts poor prognosis in patients with radical cystectomy for bladder cancer.
高单核细胞与淋巴细胞比值预示着膀胱癌根治性膀胱切除术后患者的预后不良。
Transl Cancer Res. 2020 Sep;9(9):5255-5267. doi: 10.21037/tcr-20-1060.
4
Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes.铜诱导的肿瘤细胞死亡机制及铜配合物的抗肿瘤诊断与治疗应用。
Nanomedicine (Lond). 2022 Feb;17(5):303-324. doi: 10.2217/nnm-2021-0374. Epub 2022 Jan 21.
5
PD-L1 expression and Tumor mutation burden as Pathological response biomarkers of Neoadjuvant immunotherapy for Early-stage Non-small cell lung cancer: A systematic review and meta-analysis.PD-L1 表达和肿瘤突变负担作为新辅助免疫治疗早期非小细胞肺癌的病理反应生物标志物:系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2022 Feb;170:103582. doi: 10.1016/j.critrevonc.2022.103582. Epub 2022 Jan 11.
6
Biological functions and clinical significance of long noncoding RNAs in bladder cancer.长链非编码RNA在膀胱癌中的生物学功能及临床意义
Cell Death Discov. 2021 Oct 5;7(1):278. doi: 10.1038/s41420-021-00665-z.
7
Higher Tumor Mutation Burden Was a Predictor for Better Outcome for NSCLC Patients Treated with PD-1 Antibodies: A Systematic Review and Meta-analysis.高肿瘤突变负担可预测 NSCLC 患者接受 PD-1 抗体治疗的更好结局:系统评价和荟萃分析。
SLAS Technol. 2021 Dec;26(6):605-614. doi: 10.1177/24726303211024557. Epub 2021 Jun 26.
8
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer.用于治疗膀胱癌的免疫检查点抑制剂
Cancers (Basel). 2021 Jan 3;13(1):131. doi: 10.3390/cancers13010131.
9
Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.鉴定免疫相关长链非编码 RNA 以预测膀胱癌的预后和免疫治疗反应。
Aging (Albany NY). 2020 Nov 18;12(22):23306-23325. doi: 10.18632/aging.104115.
10
Bladder Cancer: A Review.膀胱癌:综述。
JAMA. 2020 Nov 17;324(19):1980-1991. doi: 10.1001/jama.2020.17598.